Staahl, Brett T
Benekareddy, Madhurima
Coulon-Bainier, Claire
Banfal, Ashwin A
Floor, Stephen N
Sabo, Jennifer K
Urnes, Cole
Munares, Gabriela Acevedo
Ghosh, Anirvan
Doudna, Jennifer A
Article History
Received: 22 August 2016
Accepted: 31 January 2017
First Online: 13 February 2017
Competing interests
: The authors have submitted a patent disclosure on this work. J.A.D. is employed by HHMI and works at the University at California Berkeley. UC Berkeley and HHMI have patents pending for CRISPR technologies on which she is an inventor. J.A.D. is the executive director of the Innovative Genomics Institute at UC Berkeley and UCSF. J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics and Caribou Biosciences and a scientific advisor to Caribou, Intellia, eFFECTOR Therapeutics and Driver.